Comparative accuracy of qualitative and quantitative 18F-FDG PET/CT analysis in detection of lymph node metastasis from anal cancer

被引:11
作者
Chulroek, Thitinan [1 ,2 ,3 ]
Kordbacheh, Hamed [1 ]
Wangcharoenrung, Dearada [1 ,4 ]
Cattapan, Kamonwon [1 ,5 ]
Heidari, Pedram [1 ]
Harisinghani, Mukesh G. [1 ]
机构
[1] Massachusetts Gen Hosp, Dept Radiol, 55 Fruit St,White 270, Boston, MA 02114 USA
[2] Chulalongkorn Univ, Fac Med, Dept Diagnost Radiol, 1873 Rama 4 Rd, Bangkok 10330, Thailand
[3] King Chulalongkorn Mem Hosp, 1873 Rama 4 Rd, Bangkok 10330, Thailand
[4] Nawamindradhiraj Univ, Vajira Hosp, Fac Med, Dept Diagnost Radiol, 681 Samsen Rd, Bangkok 10300, Thailand
[5] Prince Songkla Univ, Dept Radiol, 15 Karnjanavanit Rd, Hat Yai, Songkhla, Thailand
关键词
Anal cancer; Squamous cell carcinoma; PET; CT; Lymph node metastasis; SUVmax; FDG PET/CT; CARCINOMA; TOMOGRAPHY; MANAGEMENT; RECURRENCE; VOLUME; HEAD;
D O I
10.1007/s00261-019-01907-6
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PurposeTo compare the diagnostic performance of qualitative and quantitative 18F-FDG PET/CT in detection of regional and distant lymph node metastasis in patients with anal cancer.MethodsBetween 2004 and 2017, 28 patients with anal cancer who had staging PET/CT and pathological assessment of suspicious lymph nodes were included. For qualitative analysis, positive lymph nodes were defined as uptake visually higher than the liver reference uptake. For quantitative study, lymph nodes were contoured to determine maximum standard uptake value (SUVmax) and metabolic tumor volume (MTV). Receiver operating characteristic (ROC) curves were plotted to extract the optimal cut-offs and area under the curve (AUC) of SUVmax, lesion to background (L/B) ratio, short axis diameter (SAD), and MTV of lymph nodes. Histopathologic analysis was a reference standard.ResultsA total of 28 lymph nodes (24 inguinal, 2 external iliac, 1 internal iliac, and 1 paraaortic nodes) in 28 patients on PET/CT were included. With the qualitative visual analysis, 19 patients were categorized as positive for nodal metastasis with sensitivity, specificity, and accuracy of 85%, 75%, and 82%. The optimal SUVmax and L/B ratio cut-offs were 2.6 and 1.0 with both sensitivity and specificity of 95% and 75% (AUC of SUVmax=0.893, AUC of L/B ratio=0.912). Using the best cut-off of 1.6cm for SAD and 3.65cm(3)for MTV, both sensitivity and specificity were 80% and 100% (AUC of SAD=0.950, AUC of MTV=0.931).ConclusionsSUV(max) optimization may be helpful in enhancing the diagnostic accuracy of 18F-FDG PET/CT in nodal staging patients with anal cancer.
引用
收藏
页码:828 / 835
页数:8
相关论文
共 26 条
[1]  
[Anonymous], 2012, AN CANC STAT
[2]   Maximum standardized uptake value on PET/CT in preoperative assessment of lymph node metastasis from thoracic esophageal squamous cell carcinoma [J].
Bella, Amos J. M. Ela ;
Zhang, Ya-Rui ;
Fan, Wei ;
Luo, Kong-Jia ;
Rong, Tie-Hua ;
Lin, Peng ;
Yang, Hong ;
Fu, Jian-Hua .
CHINESE JOURNAL OF CANCER, 2014, 33 (04) :211-217
[3]   To PET or not to PET? That is the question. Staging in anal cancer [J].
Bhuva, N. J. ;
Glynne-Jones, R. ;
Sonoda, L. ;
Wong, W. -L. ;
Harrison, M. K. .
ANNALS OF ONCOLOGY, 2012, 23 (08) :2078-2082
[4]   Diagnostic Performance of Positron Emission Tomography/Computed Tomography Using Fluorine-18 Fluorodeoxyglucose in Detecting Locoregional Nodal Involvement in Patients with Anal Canal Cancer: A Systematic Review and Meta-Analysis [J].
Caldarella, Carmelo ;
Annunziata, Salvatore ;
Treglia, Giorgio ;
Sadeghi, Ramin ;
Ayati, Narjes ;
Giovanella, Luca .
SCIENTIFIC WORLD JOURNAL, 2014,
[5]   Squamous cell carcinoma of the anal canal and anal margin [J].
Chawla, AK ;
Willett, CG .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2001, 15 (02) :321-+
[6]   Prognostic value of FDG PET/CT in head and neck squamous cell carcinomas [J].
Dequanter, D. ;
Shahla, M. ;
Aubert, C. ;
Deniz, Y. ;
Lothaire, P. .
ONCOTARGETS AND THERAPY, 2015, 8 :2279-2283
[7]  
Engstrom PF, ANAL CARCINOMA
[8]  
Gerard JP, 2001, CANCER-AM CANCER SOC, V92, P77, DOI 10.1002/1097-0142(20010701)92:1<77::AID-CNCR1294>3.0.CO
[9]  
2-P
[10]   Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up [J].
Glynne-Jones, R. ;
Nilsson, P. J. ;
Aschele, C. ;
Goh, V. ;
Peiffert, D. ;
Cervantes, A. ;
Arnold, D. .
EJSO, 2014, 40 (10) :1165-1176